HOME OUR COMPANY TECHNOLOGY & INNOVATION R&D PORTFOLIO INVESTORS PARTNERSHIPS NEWS & EVENTS CAREERS CONTACT LEARN MORE 1 2 3 4 Ablynx, a Sanofi company, is dedicated to creating new medicines which will make a real difference to society Our Products The Company has more than 45 proprietary and partnered product candidates in development Learn more. Events & Presentations Ablynx participates and presents at scientific conferences Learn more. Latest News SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE 19 June 2018 PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW") 28 May 2018 PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW") 28 May 2018 ALL NEWS >> Download No downloads to show. 2015 - 2018 © Ablynx Disclaimer Sitemap Our Company Technology & innovation R&D portfolio Investors Partnerships News & events Careers Contact

HOME OUR COMPANY TECHNOLOGY & INNOVATION R&D PORTFOLIO INVESTORS PARTNERSHIPS NEWS & EVENTS CAREERS CONTACT NANOBODIES® – CREATING BETTER MEDICINES LEARN MORE 1 2 3 4 Ablynx, a Sanofi company, is dedicated to creating new medicines which will make a real difference to society Our Products The Company has more than 45 proprietary and partnered product candidates in development Learn more. Events & Presentations Ablynx participates and presents at scientific conferences Learn more. Latest News SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE 19 June 2018 PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW") 28 May 2018 PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW") 28 May 2018 ALL NEWS >> Download No downloads to show. 2015 - 2018 © Ablynx Disclaimer Sitemap Our Company Technology & innovation R&D portfolio Investors Partnerships News & events Careers Contact